Enovis(NYSE) CFX

Enovis Corporation makes tools to help people with bone injuries. Its products help doctors treat pain and fix damaged joints. The company helps patients move better after surgery or accidents.

Tools for Recovery and Repair

• Prevention & Recovery: Provides bracing products, vascular systems, and rehabilitation equipment for orthopedic specialists and physical therapists.
• Reconstructive: Focuses on surgical implants and productivity tools for hip, knee, shoulder, and extremity procedures.

Deals and Divestitures

• Integrated LimaCorporate S.p.A. following its acquisition to expand the surgical implant business.
• Sold the Dr. Comfort Footcare Solutions U.S. operations on Oct. 7, 2025, for up to $60 million in cash.
• Completed seven strategic transactions in 2025 for $36.9 million to add new businesses and intellectual property.
• Acquired the economic rights to future royalties under product development agreements to shift to a new development model.

A Global Network for Innovation

Enovis uses a management system called Enovis Growth Excellence (EGX), which uses specific tools and processes to drive continuous improvement. The company operates production facilities across North America, Europe, North Africa, and Asia to serve a global customer base.

Looking at the Numbers

• Net sales reached $582.8 million in the three-month period ended July 3, 2026, up 3.2% year over year.
• The Reconstructive segment reported net sales of $611.7 million for the six-month period ended July 3, 2026, up 9.2% year over year.
• Gross profit margin reached 61.8% in the six-month period ended July 3, 2026, compared to 59.4% in the prior year period.
• Net cash provided by operating activities was $99.0 million for the six months ended July 3, 2026, up from $46.2 million year over year.
• Adjusted EBITDA (non-GAAP) hit $104.3 million in the three-month period ended July 3, 2026, up from $91.2 million in the prior year period.

Evolution of the Business

Enovis has transitioned from its industrial roots to a focused medical technology company through acquisitions and divestitures. Its expansion into surgical implants complements its traditional rehabilitation and recovery product lines.